Français
ItalianoBond AbbVie 2.3% ( US00287YBM03 ) in USD
| Issuer | AbbVie |
| Market price | 100 % ▼ |
| Country |  United States
|
| ISIN code |
 US00287YBM03 ( in USD )
|
| Interest rate | 2.3% per year ( payment 2 times a year) |
| Maturity | 20/11/2022 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 989 850 000 USD |
| Cusip | 00287YBM0 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) |
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBM03, pays a coupon of 2.3% per year. The coupons are paid 2 times per year and the Bond maturity is 20/11/2022 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBM03, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBM03, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |